
    
      In the parallel group, single blind, randomized controlled trial, participant underwent two
      kinds of neuroproprioceptive PT (MPAT and VRL). At baseline and after the end of the two
      months' therapeutic program, a blinded assessor evaluated clinical outcomes and data from
      serum level.
    
  